Neisseria gonorrhoeae Monoclonal Antibody (GC12-316.4), Invitrogen™

Description

• MA1-10714 detects Neisseria gonorrhoeae
• MA1-10714 has been successfully used in ELISA applications
• The MA1-10714 immunogen is UV-inactivated Neisseria gonorrhoeae cells W-I, W-II, W-III
• Although pathogenic bacteria constitute only a small portion of bacterial species, infectious diseases caused by pathogenic bacteria affect millions of people worldwide
• Diarrheal diseases, many of which are bacterial, are the second leading cause of death worldwide, claiming an estimated 5 million people annually
• Furthermore, an estimated 3 million people die of tuberculosis annually, 500,000 people die of pertussis, and 25,000 die of typhoid
• The ability of bacteria to utilize various food sources is a major factor behind their pervasiveness
• Their vast numbers lead to rapid evolutionary changes resulting in emerging diseases as well as antibiotic-resistant strains of well known diseases
• Examples of these are multi-drug resistant tuberculosis and methicillin-resistant Staphylococcus aureus
• Research into the detection and treatment of these infectious disease agents will continue to expand in an effort to alleviate the effects of these diseases.